Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
about
LRP-1: a checkpoint for the extracellular matrix proteolysisPlasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosisDirect binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activityMannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interactionToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesMatrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signalingStructural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymesCollagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalizationA two-receptor pathway for catabolism of Clara cell secretory protein in the kidneyThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilityThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingAnalysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related proteinInflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophagesThe very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro.Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.Nuclear translocation of urokinase-type plasminogen activatorBinding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.Serine protease inhibitor-E2 (SERPINE2) is differentially expressed in granulosa cells of dominant follicle in cattle.The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis.Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleCleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathwayThe putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein.Pleiotropic functions of plasminogen activator inhibitor-1.Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration.Cellular strategies for proteolytic targeting during migration and invasion.The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cellsMultiple myeloma biology: lessons from the 5TMM models.Plasminogen activator/plasmin system: a major player in wound healing?Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling.Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assembliesKnock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
P2860
Q21285122-85D8565E-1EAA-4094-B212-78203C4817BFQ24319106-FAC350AA-BED6-4BFE-9325-222FB0B71846Q24633333-1FD6D370-9C64-462A-96CA-8C2DC48866CAQ24683196-725D3197-56A2-4993-9303-3717AFA4C0CCQ26995399-91068AB9-C830-4917-A4FF-C130E318E664Q27308674-D7921D29-793D-4CAA-AE1E-EE2C20737D82Q27666429-9E048688-D976-4D03-AE8A-302CF3296DA7Q28142811-C9E74E97-7C85-4102-A3E0-CF5FC0746957Q28145656-CE2225DC-082B-4F5C-B842-6F52452FD115Q28208178-164F5D4B-26DB-44F3-AFE8-CC1ABF7E8A64Q28212178-3F27C25E-1744-42BE-BB7A-801B10A9160AQ28257803-34DADF1E-0C33-4CCE-B1AF-687EFA8033F3Q28367262-08FA46FC-F2C3-4741-A36A-61D5606DB1A3Q28585168-B308201F-C4D6-46A0-A63A-6550577549B3Q30303631-749D363C-5095-4532-866C-0ECC54614406Q30307084-CF35CB1D-C44C-4F43-827D-3074933C5916Q30482426-05E8FA14-1D8F-4D5F-948D-85A41BBB6A33Q30911713-C1307350-6FFF-4E38-B37C-ED7D9898CB1AQ33185570-7E19BD12-F098-4BBB-AF88-757729E226EBQ33199829-7200FF72-77F9-4AB4-9A36-BA537DE4F572Q33710801-89CC6F28-5569-49B6-804A-E6AFD26F87E5Q33715393-FE0C5D01-0ED9-4861-B2A1-55D085C300D0Q33816577-8CF493AD-5149-4246-B53D-10B4C47F7E4AQ33949139-DAA73D01-5510-4D51-8595-D6A25E33B888Q33984228-00F0B975-317F-4D08-8934-DF1F9AAFB8F8Q34145983-A3C7F4A3-7398-4409-A6E2-F5434A7A4BEAQ34395533-2642B498-54D4-4E54-B2AB-B0BB13EDBD30Q34584787-BFAFDD64-72A2-45A9-A6CB-999CFC76A280Q34606581-5203209D-9432-444A-8B9D-17D280C0401AQ34924478-3424AE2C-2B33-4F92-9578-54BE8BC2A61CQ35170944-C0BD410E-5149-4E58-87BC-4D156B33BE47Q35170968-AD313A34-9454-4A42-8EC2-723C6452A8F2Q35181677-557237DD-DC53-4CBA-9977-6482066DEC6AQ35219000-7986878A-4819-4F65-B7E4-6C42F6F9F1DAQ35580701-D0AA2C77-B441-43F8-9CBC-B1AFEFA79B19Q35788649-BE868542-F820-4F9C-8113-31225167F4FFQ35813903-E4EE802B-3DF4-4908-9E41-DD6DE5983F0FQ35901840-60084D40-599C-4560-8C90-CD310B7ED938Q36176567-20A08897-505B-40B6-9695-313B64DA2C28Q36311530-37008D84-71D4-4F60-AAAA-D82327755B6E
P2860
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@ast
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en-gb
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@nl
type
label
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@ast
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en-gb
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@nl
prefLabel
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@ast
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en-gb
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@nl
P2093
P2860
P356
P1433
P1476
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
@en
P2093
E I Christensen
J Gliemann
P2860
P304
P356
10.1093/EMBOJ/16.10.2610
P407
P577
1997-05-15T00:00:00Z